APA (7th ed.) Citation

Kerns, S. L., Sperk, E., Herskind, C., Veldwijk, M. R., & Chang-Claude, J. (2022). Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. Radiotherapy and oncology, 168, . https://doi.org/10.1016/j.radonc.2022.01.014

Chicago Style (17th ed.) Citation

Kerns, Sarah L., Elena Sperk, Carsten Herskind, Marlon Romano Veldwijk, and Jenny Chang-Claude. "Use of Angiotensin Converting Enzyme Inhibitors Is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer." Radiotherapy and Oncology 168 (2022). https://doi.org/10.1016/j.radonc.2022.01.014.

MLA (9th ed.) Citation

Kerns, Sarah L., et al. "Use of Angiotensin Converting Enzyme Inhibitors Is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer." Radiotherapy and Oncology, vol. 168, 2022, https://doi.org/10.1016/j.radonc.2022.01.014.